Dimensional Fund Advisors LP Kymera Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$363 Billion
Q1 2024

A detailed history of Dimensional Fund Advisors LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 349,209 shares of KYMR stock, worth $11.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

349,209

Previous 533,723 34.57%

Holding current value

$11.2 Million

Previous $13.6 Million 3.31%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$22.9 - $43.57 $4.23 Million - $8.04 Million	-184,514 Reduced 34.57%	349,209 $14 Million
Q4 2023 Feb 07, 2024	SELL	$10.97 - $26.84 $1.33 Million - $3.26 Million	-121,504 Reduced 18.54%	533,723 $13.6 Million
Q3 2023 Nov 09, 2023	SELL	$13.9 - $23.88 $2.58 Million - $4.43 Million	-185,711 Reduced 22.08%	655,227 $9.11 Million
Q2 2023 Aug 09, 2023	BUY	$22.4 - $34.92 $2.26 Million - $3.53 Million	100,947 Added 13.64%	840,938 $19.3 Million
Q1 2023 May 12, 2023	BUY	$24.84 - $38.75 $10.6 Million - $16.5 Million	426,831 Added 136.3%	739,991 $21.9 Million

Q4 2022 Feb 09, 2023	BUY	$19.57 - $30.92 $1.97 Million - $3.12 Million	100,795 Added 47.46%	313,160 $7.82 Million
Q3 2022 Nov 10, 2022	BUY	$20.91 - $34.27 $524,506 - $859,628	25,084 Added 13.39%	212,365 $4.62 Million
Q2 2022 Aug 12, 2022	SELL	$14.13 - $42.55 $712,858 - $2.15 Million	-50,450 Reduced 21.22%	187,281 $3.69 Million
Q1 2022 May 13, 2022	BUY	$35.3 - $64.68 $6.1 Million - $11.2 Million	172,839 Added 266.35%	237,731 $10.1 Million
Q4 2021 Feb 09, 2022	BUY	$49.91 - $65.56 $3.24 Million - $4.25 Million	64,892 New	64,892 $4.12 Million

Others Institutions Holding KYMR

# of Institutions

164

Shares Held

63.1M

Call Options Held

39.7K

Put Options Held

9.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $1.75B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Kymera Therapeutics, Inc. Transaction History